Welcome to our dedicated page for JBT Marel SEC filings (Ticker: JBTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
JBT Marel Corporation filings document the company's food and beverage technology business, public-company governance and capital structure. Form 8-K reports furnish quarterly and full-year results, guidance materials, Regulation FD investor presentations, segment realignment disclosures and other material corporate events tied to its Protein Solutions and Prepared Food and Beverage Solutions operations.
The company's SEC record also includes proxy disclosures on board matters, executive compensation and annual meeting governance. Capital-structure filings describe common stock and convertible senior notes due 2030, including related indenture, hedge and warrant arrangements, while officer-transition disclosures record changes in financial reporting responsibilities.
JBT MAREL Corp executive Roger Claessens reported a mix of equity award activity and tax-related share withholding. On February 25, he acquired 1,786 shares of Common Stock through a time-based restricted stock unit (RSU) grant at no purchase price, increasing his direct holdings to 3,413 shares. The RSUs settle one-for-one in Common Stock and vest ratably over three years, contingent on his continued service. On February 26, 304 shares were disposed of at $157.62 per share to cover tax obligations associated with the award, leaving him with 3,109 directly owned shares.
JBT MAREL Corp executive Shelley Rae Bridarolli reported a mix of stock awards and tax-related share withholdings. On February 25, 2026, she acquired 3,601 and 1,658 shares of Common Stock through grants and PSU settlements at no cash cost. On February 25 and 26, 2026, she disposed of 1,601 and 241 shares through tax-withholding transactions, where shares were delivered to cover exercise price or tax liabilities. After these direct transactions, she held 11,765 shares of Common Stock.
JBT MAREL Corp executive Mary Beth Siddons reported a tax-withholding disposition of common stock. The Form 4 shows she disposed of 69 shares at $163.40 per share to satisfy tax obligations related to equity, and now directly holds 2,662 common shares.
JBT MAREL Corp executive reports small share disposition for taxes. EVP & Pres., Regions & Int. Luiz Augusto Rizzolo reported a tax-withholding disposition of 298 shares of common stock on February 23, 2026 at $163.40 per share. After this transaction, he directly holds 5,498 common shares.
JBT MAREL Corp executive Robert James Petrie reported a tax-related share disposal. On this Form 4, he had 361 shares of common stock withheld at $163.40 per share to cover taxes, and he now directly holds 8,819 shares of JBT MAREL common stock.
JBT MAREL Corp Executive VP & CFO Matthew J. Meister reported a tax-related share disposition. On February 23, 2026, he transferred 441 shares of Common Stock at $163.40 per share to cover tax liabilities. After this transaction, he directly owned 15,470 shares of JBT MAREL Corp common stock.
JBT MAREL Corp CEO Brian A. Deck reported a Form 4 transaction involving a tax-withholding disposition of company shares. On February 23, 2026, he disposed of 2,069 shares of common stock at $163.40 per share to satisfy tax obligations tied to equity compensation. After this transaction, he directly owned 119,092 common shares.
JBT MAREL Corp EVP & Chief HR Officer Shelley Rae Bridarolli reported a tax-withholding disposition of 256 shares of common stock on February 23, 2026. The shares were withheld at $163.40 per share to cover tax obligations on equity compensation, leaving her with 8,348 shares held directly.
JBT Marel Corporation reported strong top-line growth for 2025 while absorbing large integration and pension charges. Revenue from continuing operations reached $3.8 billion, with about 50% from recurring revenue, and full-year adjusted EBITDA was $600.4 million, a 15.8% margin. GAAP loss from continuing operations was $49.7 million, or $0.96 per diluted share, driven by $179 million of acquisition-related amortization and depreciation, $147 million of non-cash U.S. pension settlement charges, $114.5 million of M&A costs, and $30.7 million of restructuring costs. Orders were about $3.8 billion with year-end backlog of $1.372 billion, and free cash flow was $249.8 million. Net debt to trailing twelve-month adjusted EBITDA was 2.9x. For 2026, the company guides revenue to $3.99–$4.07 billion, income from continuing operations margin of 6.1–6.6%, adjusted EBITDA margin of 17.0–17.5%, GAAP EPS of $4.70–$5.15, and adjusted EPS of $8.00–$8.50.
JBT Marel Corporation has realigned its reporting structure to reflect integration after its January 2, 2025 acquisition of Marel hf. Effective in the fourth quarter of 2025, the company now reports two segments: Protein Solutions and Prepared Food and Beverage Solutions.
The chief executive officer now reviews results under this new structure, and historical segment data have been recast. Exhibit 99.1 provides segment revenue and Segment Adjusted EBITDA for the quarters ended March 31, June 30 and September 30, 2025 and for the years ended December 31, 2024 and 2023. The company states these changes do not affect previously reported consolidated net revenue, net earnings, earnings per share or total assets.